Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 16 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 289.90M | $ 377.60M | $ 144.80M | $ 134.74M | $ 18.74M |
Total Assets | $ 2.11B | $ 2.08B | $ 1.44B | $ 1.16B | $ 766.80M |
Total Debt | $ 104.30M | $ 118.40M | $ 136.20M | $ 86.30M | $ 63.14M |
Net Debt | $ -185.60M | $ -259.20M | $ -8.60M | $ -48.44M | $ 44.40M |
Total Liabilities | $ 427.30M | $ 554.10M | $ 461.20M | $ 281.08M | $ 225.13M |
Stockholders Equity | $ 1.68B | $ 1.52B | $ 973.80M | $ 874.55M | $ 541.67M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |